What are the unexpected impacts of upcoming Canadian medicine pricing regulations?
A new CHÉOS-led project aims to help decision makers understand the effects of pharmaceutical policy changes
Read MoreJune 3, 2021
Data and research that provides insight into the economics of health policies and practices is vital to help governments and policymakers make decisions about spending while balancing tradeoffs. CHÉOS investigators are leaders in this field. Their work has been instrumental in informing budgets, health care policies, and guidelines at all levels of government.
A new CHÉOS-led project aims to help decision makers understand the effects of pharmaceutical policy changes
Read More
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read More
A new investigation from the CHÉOS Health Economics Program indicates the framework could speed up generic entry to Canadian public health plans
Read More
New research from the CHÉOS Health Economics Program finds market factors and pricing policies may be to blame
Read More
CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
Read More
In recognition of World Hepatitis Day on July 28, CHÉOS Scientist Dr. Naveed Janjua discusses the BC Hepatitis Testers Cohort
Read More